2018
DOI: 10.1007/s11011-018-0282-7
|View full text |Cite
|
Sign up to set email alerts
|

Neuroinflammation in acute hepatic encephalopathy rats: imaging and therapeutic effectiveness evaluation using 11C-PK11195 and 18F-DPA-714 micro-positron emission tomography

Abstract: Neuroinflammation has an important influence in pathogenesis of acute hepatic encephalopathy (AHE). C-PK11195 andF-DPA-714 targeted to translocator protein (TSPO) have potential application in positron emission tomography (PET) as a molecular probe of neuroinflammation. The aim of this study was to compare these two radiotracers and their effectiveness in detecting neuroinflammation for the imaging of AHE rat models. Furthermore, using the new radiotracer F-DPA-714, we analyzed the effectiveness of therapeutic… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
13
0

Year Published

2019
2019
2024
2024

Publication Types

Select...
6
1

Relationship

2
5

Authors

Journals

citations
Cited by 8 publications
(14 citation statements)
references
References 40 publications
1
13
0
Order By: Relevance
“…All subjects were randomized into two groups: sham group (n = 8) or BDL group (n = 12). The sample size was determined by considering the mortality rate according to previous studies (Kong et al, 2016;Luo et al, 2018). Details regarding the BDL procedure are described in the Supplementary Materials.…”
Section: Animal Modelmentioning
confidence: 99%
See 2 more Smart Citations
“…All subjects were randomized into two groups: sham group (n = 8) or BDL group (n = 12). The sample size was determined by considering the mortality rate according to previous studies (Kong et al, 2016;Luo et al, 2018). Details regarding the BDL procedure are described in the Supplementary Materials.…”
Section: Animal Modelmentioning
confidence: 99%
“…Detailed procedures are described in the Supplementary Materials. (Fookes et al, 2008;Lavisse et al, 2015;Kong et al, 2016;Luo et al, 2018). Procedures for the synthesis of [ 18 F]DPA-714 and [ 18 F]PBR146 are provided in the Supplementary Materials.…”
Section: Behavioral Studiesmentioning
confidence: 99%
See 1 more Smart Citation
“…86 In the context of acute HE, 11 C-PK1195 and 18 F-DPA-714 have been used and found to detect neuroinflammation in thioacetamide-treated rats by binding to translocator protein. 87 Interestingly, translocator protein has been deleted from astrocytes, demonstrating an increase of mitochondria permeability transition and cell volume in response to ammonia, indicating that this protein is involved in more processes than just neuroinflammation. 88 That being said, not all evidence shows induction of a proinflammatory phenotype during HE as microglia polarization occurs in cirrhotic patients, with both pro-inflammatory M1 and anti-inflammatory M2 phenotypes being present.…”
Section: Microglia Activationmentioning
confidence: 99%
“…The first-generation radioligand [ 11 C](R)-PK11195 has been the most widely studied in clinical studies and different neurodegenerative diseases, including multiple sclerosis (Airas et al, 2018), Creutzfeldt-Jakob disease (Iaccarino et al, 2018), and also in psychiatric disorders such as schizophrenia (Di Biase et al, 2017). Although the findings of an increased uptake of this tracer in these pathologies, limitations including low signalto-noise ratio and high non-specific binding has addressed for the synthesis of second-and third-generation TSPO-specific radiopharmaceuticals, linked to [ 11 C] or [ 18 F] and including (Luo et al, 2018;Singhal et al, 2018;Best et al, 2019). Similarly, different studies have reported selective microglial uptake of these tracers in multiple sclerosis animal models and patients (Hagens et al, 2018;Herranz et al, 2019;Nack et al, 2019), amyotrophic lateral sclerosis (Zürcher et al, 2015;Datta et al, 2017), Alzheimer's disease (Alam et al, 2017;Keller et al, 2018;Focke et al, 2019), and Lyme disease on humans (Coughlin et al, 2018), and stroke experimental models (Miyajima et al, 2018), with more discordant results for psychiatric patients, suffering from schizophrenia (Di Biase et al, 2017;Hafizi et al, 2017;Ottoy et al, 2018;Selvaraj et al, 2018) and major depression (Li et al, 2018), probably due to the different stage of disease.…”
Section: Pet and Mr Imaging Of Microglial Activationmentioning
confidence: 99%